ACG 6175 Summer 2015 Week 7 Assignment

J.P. Morgan Tells Analysts To Warn of a Downgrade

By Wade Lambert and Jathon Sapsford

Staff Reporters of The Wall Street Journal

March 22, 2001

J.P. Morgan Chase & Co.'s head of European research told his team of analysts they must run all

changes in European stock recommendations past both the company in question and J.P.

Morgan's investment-banking department.

"Both the company and the client banker need to be notified, in advance, of the recommendation

change that we plan to make," said the memo, written by Peter Houghton, head of equity research

in Europe. "If the company requests changes to the research note, the analyst has a responsibility

to either incorporate the changes requested or communicate clearly why the changes cannot be

made."

The memo, which a company spokesman described as a global policy for the bank and which was

previously reported by the Times of London, represents a rare written edict on a practice that

raises questions about analysts' independence.

Wall Street analysts long have been pressured by corporate clients and their own bankers to shun

negative research. Some companies penalize analysts or their firms for "sell" recommendations.

Investment bankers pressure analysts because they fear any negative research will hamper their

chances of winning lucrative underwriting or advisory business from the same corporate client.

Thus, many savvy investors ignore much of the research that comes from securities firms.

"It defeats the purpose of research," says Frank Barkocy, director of research at hedge fund Keefe

Managers. Mr. Barkocy represents the "buy side," or those who are potential customers for the

research of analysts at Wall Street securities firms who are known as the "sell side."

By showing the report first to the company in question, "the way an analyst uses some words might

very well be minimized," Mr. Barkocy says. "It's a disservice to the analyst and a disservice to the

buy side."

J.P. Morgan Chase maintains the memo merely reiterates a policy it has long followed, and that it

reflects practices that are common in the industry. The company says it sent the memo to ensure

that several new analysts who came from other firms know the policy. The company maintains that

analysts aren't under pressure to change recommendations, but only to make factual changes.

"The point of the memo was to ensure that there's clear communication between analysts and

bankers and companies," says Nick O'Donohoe, head of European equities at J.P. Morgan. It is "a

normal, common courtesy" to warn a company that an analyst was about to downgrade its stock.

Nothing in the memo "compromises the honesty or objectivity or independence of our analysts," he

says.

Analysts' practices are coming under increased scrutiny after the Securities and Exchange

Commission last October began enforcing Regulation FD, for fair disclosure, a rule that seeks to

rein in the flow of privileged information between corporations and the Wall Street analysts who

cover them. Wall Street analysts also have been criticized for maintaining "buy" recommendations

on once-highflying tech stocks, despite their lack of profits, and long after their stocks had fallen.

The issue came to a head for many European investors in December over the initial public offering

for France Telecom's Orange PLC unit. Analysts were barred from a briefing by Orange officials

unless they agreed to let the lead banks "fact-check" their reports on the share offering.

Some question whether research can ever be considered objective if the other arm of the firm

publishing it is advising the same company on a merger or selling shares. Sebastian Virchow, a

fund manager at Deutsche Bank AG's asset-management unit DWS Group in Frankfurt, says his

team confirms the earnings and scientific developments of the companies it invests in, rather than 

taking analysts' reports at face value. "We read the analyst reports and gather information, but we

do our own due diligence and would never just use the reports on their own," he says. "We talk to

the companies ourselves and make our own earnings estimates."

Need these answered based on article attached. 

1. What is meant by "analysts' independence"? When and how might analysts' independence be compromised? What pressures do analysts face that might reduce their independence? Is maintaining a "buy" recommendation on a stock after its price has fallen evidence that an analysts' independence is compromised? Do analysts who currently recommend investing in tech stocks and the broader stock market lack independence?
2. What exactly does Peter Houghton's memo say? Does the memo say that analysts should compromise their independence? How does the memo raise questions about analysts' independence? Does it make any difference whether "analysts aren't pressured to change recommendations, but only to make factual changes"?
3. What are the "buy side" and "sell side"? Why might the "sell side" be unwilling to make "sell" recommendations on stocks? If the "buy side" has its own analysts, would the "buy side" ever look at "sell side" analysts' reports?
4. Why might "sell side" companies extend the "normal, common courtesy" of warning firms before they downgrade their stocks? Would you consider this good business practice? What is Mr. Barkocy's "buy side" criticism of such practices? Why might the "sell side" ignore such criticism?
5. Former SEC chairman, Arthur Levitt, criticized analysts in January this year in a speech in Philadelphia. Read the speech "The Future for America’s Investors". Levitt comments that a "sell" recommendation from an analyst is as common as a Philly steak sandwich without the cheese. If analysts don't issue "sell" recommendations, how do they advise investors that they should sell certain stocks?